STOCK TITAN

[8-K] Nukkleus Inc. Warrants Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Melar Acquisition Corp. I (Nasdaq: MACIU/MACI/MACIW) filed an 8-K stating that on 30-Jul-2025 it executed a definitive Agreement and Plan of Merger with Everli Global Inc. The SPAC will first domesticate from the Cayman Islands to Nevada, then merge its wholly-owned Merger Sub into Everli. Everli will become a wholly owned subsidiary and its equity-holders will receive Melar common stock; certain holders will obtain Melar super-voting shares, mirroring Everli’s dual-class structure.

The agreement assigns Everli a pre-money equity value of $180 million, subject to upward adjustment for financings completed before closing. A joint press release (Ex 99.1) and investor presentation (Ex 99.2) were furnished. A Form S-4 containing the proxy/prospectus will be filed with the SEC; completion remains contingent on SEC effectiveness, shareholder approvals, continued Nasdaq listing and other customary conditions.

No historical financial results or guidance were provided. The filing contains standard forward-looking statement and no-offer disclaimers.

Melar Acquisition Corp. I (Nasdaq: MACIU/MACI/MACIW) ha depositato un modulo 8-K dichiarando che il 30 luglio 2025 ha sottoscritto un Accordo e Piano di Fusione definitivo con Everli Global Inc. La SPAC procederà prima alla domiciliazione dalle Isole Cayman al Nevada, per poi fondere la sua controllata interamente posseduta Merger Sub in Everli. Everli diventerà una controllata al 100% e i suoi azionisti riceveranno azioni ordinarie Melar; alcuni azionisti otterranno azioni Melar con super-voto, replicando la struttura a doppia classe di Everli.

L'accordo attribuisce a Everli un valore azionario pre-money di 180 milioni di dollari, soggetto a possibili aumenti in caso di finanziamenti completati prima della chiusura. Sono stati forniti un comunicato stampa congiunto (Ex 99.1) e una presentazione per gli investitori (Ex 99.2). Verrà depositato presso la SEC un modulo S-4 contenente la procura/prospetto; il completamento resta subordinato all'efficacia della SEC, alle approvazioni degli azionisti, al mantenimento della quotazione Nasdaq e ad altre condizioni consuete.

Non sono stati forniti risultati finanziari storici né previsioni. Il deposito include le tipiche dichiarazioni previsionali e clausole di esclusione di offerta.

Melar Acquisition Corp. I (Nasdaq: MACIU/MACI/MACIW) presentó un formulario 8-K indicando que el 30 de julio de 2025 firmó un Acuerdo y Plan Definitivo de Fusión con Everli Global Inc. La SPAC primero cambiará su domicilio de las Islas Caimán a Nevada, y luego fusionará su subsidiaria Merger Sub de propiedad total en Everli. Everli se convertirá en una subsidiaria totalmente controlada y sus accionistas recibirán acciones ordinarias de Melar; algunos accionistas obtendrán acciones con súper voto de Melar, reflejando la estructura de doble clase de Everli.

El acuerdo asigna a Everli un valor patrimonial pre-money de 180 millones de dólares, sujeto a ajustes al alza por financiamientos completados antes del cierre. Se proporcionaron un comunicado de prensa conjunto (Ex 99.1) y una presentación para inversionistas (Ex 99.2). Se presentará un formulario S-4 ante la SEC que contiene el poder/prospecto; la finalización depende de la efectividad de la SEC, aprobaciones de accionistas, mantenimiento de la cotización en Nasdaq y otras condiciones habituales.

No se proporcionaron resultados financieros históricos ni proyecciones. La presentación incluye declaraciones prospectivas estándar y avisos de no oferta.

Melar Acquisition Corp. I (나스닥: MACIU/MACI/MACIW)는 2025년 7월 30일 Everli Global Inc.와 확정된 합병 계약 및 계획서를 체결했다고 8-K 보고서에 밝혔습니다. SPAC은 먼저 케이맨 제도에서 네바다로 법인 소재지를 이전한 후, 완전 소유한 합병 자회사(Merger Sub)를 Everli에 합병할 예정입니다. Everli는 완전 자회사가 되며, 주주들은 Melar 보통주를 받게 되고 일부 주주는 Everli의 이중 클래스 구조를 반영한 Melar의 초과 의결권 주식을 받게 됩니다.

본 계약은 Everli에 대해 1억 8천만 달러의 사전 가치(pre-money equity value)를 부여하며, 종결 전 완료된 자금 조달에 따라 상향 조정될 수 있습니다. 공동 보도자료(Ex 99.1)와 투자자 프레젠테이션(Ex 99.2)이 제공되었습니다. SEC에 위임장/설명서가 포함된 S-4 양식이 제출될 예정이며, 완료는 SEC 승인, 주주 승인, 나스닥 상장 유지 및 기타 통상적인 조건 충족을 전제로 합니다.

과거 재무 실적이나 가이던스는 제공되지 않았습니다. 제출 문서에는 표준적인 미래 예측 진술과 비공개 제안 면책 조항이 포함되어 있습니다.

Melar Acquisition Corp. I (Nasdaq : MACIU/MACI/MACIW) a déposé un formulaire 8-K indiquant que le 30 juillet 2025, elle a signé un Accord et Plan de Fusion définitif avec Everli Global Inc. La SPAC procédera d'abord à la domiciliation des îles Caïmans vers le Nevada, puis fusionnera sa filiale détenue à 100 % Merger Sub dans Everli. Everli deviendra une filiale à part entière et ses actionnaires recevront des actions ordinaires Melar ; certains détenteurs obtiendront des actions Melar à droit de vote multiple, reflétant la structure à double classe d'Everli.

L'accord attribue à Everli une valorisation pré-money de 180 millions de dollars, sujette à une augmentation en cas de financements réalisés avant la clôture. Un communiqué de presse conjoint (Ex 99.1) et une présentation aux investisseurs (Ex 99.2) ont été fournis. Un formulaire S-4 contenant la procuration/prospectus sera déposé auprès de la SEC ; la réalisation dépend de l'efficacité auprès de la SEC, des approbations des actionnaires, du maintien de la cotation Nasdaq et d'autres conditions habituelles.

Aucun résultat financier historique ni aucune prévision n'ont été communiqués. Le dépôt contient les déclarations prospectives habituelles et des clauses de non-offre.

Melar Acquisition Corp. I (Nasdaq: MACIU/MACI/MACIW) hat in einem 8-K-Bericht mitgeteilt, dass am 30. Juli 2025 ein endgültiger Verschmelzungs- und Fusionsplan mit Everli Global Inc. abgeschlossen wurde. Die SPAC wird zunächst ihren Sitz von den Cayman Islands nach Nevada verlegen und anschließend ihre vollständig im Eigentum stehende Merger Sub in Everli einbringen. Everli wird eine hundertprozentige Tochtergesellschaft, und die Anteilseigner erhalten Melar-Stammaktien; bestimmte Anteilseigner erhalten Melar Super-Voting-Aktien, die die duale Kapitalstruktur von Everli widerspiegeln.

Die Vereinbarung bewertet Everli mit einem Pre-Money-Eigenkapitalwert von 180 Millionen US-Dollar, vorbehaltlich einer Aufwertung durch vor Abschluss abgeschlossene Finanzierungen. Eine gemeinsame Pressemitteilung (Ex 99.1) und eine Investorenpräsentation (Ex 99.2) wurden bereitgestellt. Ein Formular S-4 mit der Vollmacht/Prospekt wird bei der SEC eingereicht; der Abschluss hängt von der Wirksamkeit bei der SEC, Aktionärszustimmungen, dem Fortbestand der Nasdaq-Notierung und weiteren üblichen Bedingungen ab.

Es wurden keine historischen Finanzergebnisse oder Prognosen bereitgestellt. Die Einreichung enthält die üblichen zukunftsgerichteten Aussagen und Haftungsausschlüsse bezüglich eines Angebots.

Positive
  • Definitive merger agreement signed with Everli Global Inc., ending Melar’s target search.
  • $180 million pre-money valuation provides a clear benchmark for investors.
  • Planned domestication to Nevada may simplify governance and reduce regulatory friction.
Negative
  • Deal requires multiple approvals (SEC effectiveness, shareholder votes, Nasdaq listing) before closing.
  • No committed PIPE financing disclosed, leaving funding and redemption risk unresolved.
  • Forward-looking statements highlight potential termination and litigation risks.

Insights

TL;DR: $180 m Everli deal gives Melar a clear de-SPAC path; shareholder and regulatory approvals still pending.

The signing of a definitive merger agreement is a major milestone for Melar, which had been seeking a target since its 2022 IPO. The $180 million pre-money valuation provides investors with a firm benchmark and suggests a modest sub-$1 billion post-transaction market cap that may attract small-cap growth investors. Domestication to Nevada should streamline governance versus a Cayman structure and is typical in recent de-SPACs. Although no PIPE financing was disclosed, the deal could still tap capital markets before closing, potentially improving Everli’s balance-sheet flexibility. Overall, announcement materially advances the SPAC’s investment thesis.

TL;DR: Execution risk high—closing hinges on votes, SEC clearance, Nasdaq listing and possible additional financing.

The transaction faces multiple gating items: SEC review of the S-4, Melar and Everli shareholder approvals, and confirmation that the combined company meets Nasdaq listing standards. Lack of a committed PIPE raises uncertainty around post-merger liquidity and potential redemptions. Forward-looking statements flag several risks, including litigation and the ability to raise follow-on capital. Investors should monitor redemption levels and any financing updates before forming a view on deal certainty.

Melar Acquisition Corp. I (Nasdaq: MACIU/MACI/MACIW) ha depositato un modulo 8-K dichiarando che il 30 luglio 2025 ha sottoscritto un Accordo e Piano di Fusione definitivo con Everli Global Inc. La SPAC procederà prima alla domiciliazione dalle Isole Cayman al Nevada, per poi fondere la sua controllata interamente posseduta Merger Sub in Everli. Everli diventerà una controllata al 100% e i suoi azionisti riceveranno azioni ordinarie Melar; alcuni azionisti otterranno azioni Melar con super-voto, replicando la struttura a doppia classe di Everli.

L'accordo attribuisce a Everli un valore azionario pre-money di 180 milioni di dollari, soggetto a possibili aumenti in caso di finanziamenti completati prima della chiusura. Sono stati forniti un comunicato stampa congiunto (Ex 99.1) e una presentazione per gli investitori (Ex 99.2). Verrà depositato presso la SEC un modulo S-4 contenente la procura/prospetto; il completamento resta subordinato all'efficacia della SEC, alle approvazioni degli azionisti, al mantenimento della quotazione Nasdaq e ad altre condizioni consuete.

Non sono stati forniti risultati finanziari storici né previsioni. Il deposito include le tipiche dichiarazioni previsionali e clausole di esclusione di offerta.

Melar Acquisition Corp. I (Nasdaq: MACIU/MACI/MACIW) presentó un formulario 8-K indicando que el 30 de julio de 2025 firmó un Acuerdo y Plan Definitivo de Fusión con Everli Global Inc. La SPAC primero cambiará su domicilio de las Islas Caimán a Nevada, y luego fusionará su subsidiaria Merger Sub de propiedad total en Everli. Everli se convertirá en una subsidiaria totalmente controlada y sus accionistas recibirán acciones ordinarias de Melar; algunos accionistas obtendrán acciones con súper voto de Melar, reflejando la estructura de doble clase de Everli.

El acuerdo asigna a Everli un valor patrimonial pre-money de 180 millones de dólares, sujeto a ajustes al alza por financiamientos completados antes del cierre. Se proporcionaron un comunicado de prensa conjunto (Ex 99.1) y una presentación para inversionistas (Ex 99.2). Se presentará un formulario S-4 ante la SEC que contiene el poder/prospecto; la finalización depende de la efectividad de la SEC, aprobaciones de accionistas, mantenimiento de la cotización en Nasdaq y otras condiciones habituales.

No se proporcionaron resultados financieros históricos ni proyecciones. La presentación incluye declaraciones prospectivas estándar y avisos de no oferta.

Melar Acquisition Corp. I (나스닥: MACIU/MACI/MACIW)는 2025년 7월 30일 Everli Global Inc.와 확정된 합병 계약 및 계획서를 체결했다고 8-K 보고서에 밝혔습니다. SPAC은 먼저 케이맨 제도에서 네바다로 법인 소재지를 이전한 후, 완전 소유한 합병 자회사(Merger Sub)를 Everli에 합병할 예정입니다. Everli는 완전 자회사가 되며, 주주들은 Melar 보통주를 받게 되고 일부 주주는 Everli의 이중 클래스 구조를 반영한 Melar의 초과 의결권 주식을 받게 됩니다.

본 계약은 Everli에 대해 1억 8천만 달러의 사전 가치(pre-money equity value)를 부여하며, 종결 전 완료된 자금 조달에 따라 상향 조정될 수 있습니다. 공동 보도자료(Ex 99.1)와 투자자 프레젠테이션(Ex 99.2)이 제공되었습니다. SEC에 위임장/설명서가 포함된 S-4 양식이 제출될 예정이며, 완료는 SEC 승인, 주주 승인, 나스닥 상장 유지 및 기타 통상적인 조건 충족을 전제로 합니다.

과거 재무 실적이나 가이던스는 제공되지 않았습니다. 제출 문서에는 표준적인 미래 예측 진술과 비공개 제안 면책 조항이 포함되어 있습니다.

Melar Acquisition Corp. I (Nasdaq : MACIU/MACI/MACIW) a déposé un formulaire 8-K indiquant que le 30 juillet 2025, elle a signé un Accord et Plan de Fusion définitif avec Everli Global Inc. La SPAC procédera d'abord à la domiciliation des îles Caïmans vers le Nevada, puis fusionnera sa filiale détenue à 100 % Merger Sub dans Everli. Everli deviendra une filiale à part entière et ses actionnaires recevront des actions ordinaires Melar ; certains détenteurs obtiendront des actions Melar à droit de vote multiple, reflétant la structure à double classe d'Everli.

L'accord attribue à Everli une valorisation pré-money de 180 millions de dollars, sujette à une augmentation en cas de financements réalisés avant la clôture. Un communiqué de presse conjoint (Ex 99.1) et une présentation aux investisseurs (Ex 99.2) ont été fournis. Un formulaire S-4 contenant la procuration/prospectus sera déposé auprès de la SEC ; la réalisation dépend de l'efficacité auprès de la SEC, des approbations des actionnaires, du maintien de la cotation Nasdaq et d'autres conditions habituelles.

Aucun résultat financier historique ni aucune prévision n'ont été communiqués. Le dépôt contient les déclarations prospectives habituelles et des clauses de non-offre.

Melar Acquisition Corp. I (Nasdaq: MACIU/MACI/MACIW) hat in einem 8-K-Bericht mitgeteilt, dass am 30. Juli 2025 ein endgültiger Verschmelzungs- und Fusionsplan mit Everli Global Inc. abgeschlossen wurde. Die SPAC wird zunächst ihren Sitz von den Cayman Islands nach Nevada verlegen und anschließend ihre vollständig im Eigentum stehende Merger Sub in Everli einbringen. Everli wird eine hundertprozentige Tochtergesellschaft, und die Anteilseigner erhalten Melar-Stammaktien; bestimmte Anteilseigner erhalten Melar Super-Voting-Aktien, die die duale Kapitalstruktur von Everli widerspiegeln.

Die Vereinbarung bewertet Everli mit einem Pre-Money-Eigenkapitalwert von 180 Millionen US-Dollar, vorbehaltlich einer Aufwertung durch vor Abschluss abgeschlossene Finanzierungen. Eine gemeinsame Pressemitteilung (Ex 99.1) und eine Investorenpräsentation (Ex 99.2) wurden bereitgestellt. Ein Formular S-4 mit der Vollmacht/Prospekt wird bei der SEC eingereicht; der Abschluss hängt von der Wirksamkeit bei der SEC, Aktionärszustimmungen, dem Fortbestand der Nasdaq-Notierung und weiteren üblichen Bedingungen ab.

Es wurden keine historischen Finanzergebnisse oder Prognosen bereitgestellt. Die Einreichung enthält die üblichen zukunftsgerichteten Aussagen und Haftungsausschlüsse bezüglich eines Angebots.

false 0001787518 0001787518 2025-07-30 2025-07-30 0001787518 NUKK:CommonStock0.0001ParValuePerShareMember 2025-07-30 2025-07-30 0001787518 NUKK:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor92.00PerShareMember 2025-07-30 2025-07-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 30, 2025

 

NUKKLEUS INC.

(Exact name of registrant as specified in its charter)

 

Delaware

  001-39341   38-3912845
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (IRS Employer
Identification Number)

 

525 Washington Blvd.

Jersey City, New Jersey 07310

(Address of principal executive offices)

 

212-791-4663

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: 

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   NUKK   The Nasdaq Stock Market LLC
         
Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share   NUKKW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On July 30, 2025, Nukkleus Inc. (“Nukkleus” or the “Company”) entered into a warrant agreement (the “Warrant”) with Synthetic Darwin LLC, a Delaware limited liability company (“Darwin”), enabling Nukkleus to acquire up to 200 million of Darwin tokens, a new class of self-evolving AI network tokens developed by Darwin. The Company paid $500 for the Warrant, which is exercisable until July 30, 2026.

 

Under the terms of the Warrant, Nukkleus has the right to exercise the warrant and purchase 50 million tokens every three months, with an exercise price for the initial 50 million tokens of $0.02 per token; an exercise price of $0.05 per token for the second 50 million tranche; an exercise price of $0.1 for the third tranche; and $0.50 for the fourth 50 million tranche of tokens. Upon issuance, the Company exercised the initial tranche and received 50 million Darwin tokens. The Company can pay for the Darwin tokens with Nukkleus shares, US dollar stablecoins acceptable to Darwin, cash or any combination thereof. Any cashless exercise of the Warrant by the Company is based on the fair market value of the token on www.coinmarketcap.com.

 

The tokens purchased by the Company are subject to a 6-month lockup if other tokens issued by Darwin are also subject to a minimum of a 6-month lockup.

 

If Darwin or an affiliate mints, generates or creates additional warrants, Nukkleus shall be entitled to its portion of the total network tokens (which is 999,999,999 tokens). The Company shall also be entitled to a pro rata portion of any additional, alternative or derivative digital asset if the underlying blockchain protocol of the token undergoes any split, fork, clone, airdrop or similar event.

 

In addition, Nukkleus is entitled to receive pro-rata allocations in the event Darwin or any affiliated entity issues additional tokens or derivative digital assets (e.g., via forks or staking distributions). All tokens issued to Nukkleus will carry lock-up governance rights basis relative to other insiders and founders.

 

Darwin and its founder agreed that they will not seek to utilize or exploit for commercial purposes any blockchain-based network protocol, platform or application without first obtaining the consent of Nukkleus.

 

The above description of the Warrant is qualified in its entirety by reference to the Warrant, a copy of which is attached hereto as Exhibit 10.1.  

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No

  Description
10.1   Warrant Agreement dated July 30, 2025 issued by Synthetic Darwin LLC to Nukkleus Inc..
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

NUKKLEUS INC.
     
Date: July 31, 2025 By: /s/ Menachem Shalom
  Name:  Menachem Shalom
  Title: Chief Executive Officer

 

 

2

 

 

 

FAQ

What transaction did Melar Acquisition Corp. I (MACIW) announce?

Melar signed a definitive merger agreement to combine with Everli Global Inc. at a $180 million pre-money valuation.

Will Melar change its jurisdiction before the merger?

Yes. The SPAC will redomicile from the Cayman Islands to Nevada prior to merging with Everli.

What securities filings should investors watch for next?

A Form S-4 containing the proxy statement/prospectus will be filed with the SEC before the shareholder vote.

Are any financial results or projections included in this 8-K?

No. The current filing provides no historical financials or forecasts for Everli or Melar.

What are the main conditions to closing the Everli merger?

Key conditions include SEC clearance of the S-4, shareholder approvals, Nasdaq listing qualification and customary closing conditions.
Nukkleus

NASDAQ:NUKKW

NUKKW Rankings

NUKKW Latest News

NUKKW Latest SEC Filings

NUKKW Stock Data

36.28M
367.18M
Software - Application
Services-management Consulting Services
Link
United States
JERSEY CITY